So with "over 4200 patient-years of safety data across ten trials"   who thinks this team may be able to shake up an EU or FDA emergency use trial for patients with a glioblastoma who are now  experiencing TMZ resistance (like two people I knew personally who died in short order after TMZ stopped working on their tumor) ?  Seems like the data is building, would be nice.